FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Medique Products Extra Strength Headache Recall

Extra Strength Headache (acetaminophen 250 mg, aspirin 250 mg, caffeine 65 mg) tablets,…

Medique Products · Fort Myers, FL

Risk level
Class II
Reported by FDA
Jan 26, 2022
Recall ID
D-0391-2022
Check your lot numberHow we source this data

Summary

Medique Products recalled Extra Strength Headache starting Dec 6, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0391-2022 on Jan 26, 2022. Reason: CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices. Status: Terminated.

Why it was recalled

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Product description

Extra Strength Headache (acetaminophen 250 mg, aspirin 250 mg, caffeine 65 mg) tablets, packaged in 2-count tablets per packet, Manufactured for: Lil' Drug Store Products, Inc., Cedar Rapids, IA 52404

Lot numbers, UPCs & expiration codes

Lots: 6492 Exp. 06/2022; 6701 Exp. 10/2022; 6750 Exp. 12/2022; 6853 Exp. 01/2023; 6854 Exp. 01/2023; 6869 Exp. 02/2023; 6898 Exp. 02/2023; 6901 Exp. 02/2023; 7059 Exp. 05/2023; 7060 Exp. 05/2023; 7064 Exp. 06/2023; 7065 Exp. 06/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0391-2022
Classification
Class II
Status
Terminated
Recall initiated
Dec 6, 2021
FDA report date
Jan 26, 2022
Quantity
6,639,838 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Medique Products

Original FDA data

Every field from FDA enforcement report D-0391-2022, exactly as published.

Show all FDA fields
City
Fort Myers
State
FL
Status
Terminated
Country
United States
Event ID
89356
Address
17080 Alico Commerce Ct Ste 1
Code information
Lots: 6492 Exp. 06/2022; 6701 Exp. 10/2022; 6750 Exp. 12/2022; 6853 Exp. 01/2023; 6854 Exp. 01/2023; 6869 Exp. 02/2023; 6898 Exp. 02/2023; 6901 Exp. 02/2023; 7059 Exp. 05/2023; 7060 Exp. 05/2023; 7064 Exp. 06/2023; 7065 Exp. 06/2023
Postal code
33967-8509
Report date
Jan 26, 2022
Product type
Drugs
Recall number
D-0391-2022
Classification
Class II
Recalling firm
Medique Products
Product quantity
6,639,838 tablets
Termination date
Jun 21, 2023
Reason for recall
CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Extra Strength Headache (acetaminophen 250 mg, aspirin 250 mg, caffeine 65 mg) tablets, packaged in 2-count tablets per packet, Manufactured for: Lil' Drug Store Products, Inc., Cedar Rapids, IA 52404
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 6, 2021
Initial firm notification
Letter
Center classification date
Jan 20, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0391-2022, published Jan 26, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls